DENTSPLY SIRONA Inc. [NASDAQ: XRAY] price surged by 10.19 percent to reach at $3.52. The company report on February 28, 2023 that Dentsply Sirona Reports Fourth Quarter and Full Year 2022 Results, Provides Full Year 2023 Outlook.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
FY22 net sales decreased (7.3%) to $3,922 million, organic sales decreased (0.5%).
A sum of 5995014 shares traded at recent session while its average daily volume was at 1.95M shares. DENTSPLY SIRONA Inc. shares reached a high of $38.92 and dropped to a low of $36.49 until finishing in the latest session at $38.07.
The one-year XRAY stock forecast points to a potential downside of -4.7. The average equity rating for XRAY stock is currently 2.50, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on DENTSPLY SIRONA Inc. [XRAY]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for XRAY shares is $36.36 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on XRAY stock is a recommendation set at 2.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for DENTSPLY SIRONA Inc. shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on January 12, 2023. The new note on the price target was released on August 05, 2022, representing the official price target for DENTSPLY SIRONA Inc. stock. Previously, the target price had yet another drop from $58 to $47, while UBS kept a Buy rating on XRAY stock.
The Average True Range (ATR) for DENTSPLY SIRONA Inc. is set at 1.20, with the Price to Sales ratio for XRAY stock in the period of the last 12 months amounting to 2.09. The Price to Book ratio for the last quarter was 2.26, with the Price to Cash per share for the same quarter was set at 1.90. Price to Free Cash Flow for XRAY in the course of the last twelve months was 18.57 with Quick ratio for the last quarter at 1.00.
XRAY Stock Performance Analysis:
DENTSPLY SIRONA Inc. [XRAY] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.54. With this latest performance, XRAY shares gained by 2.89% in over the last four-week period, additionally plugging by 13.27% over the last 6 months – not to mention a drop of -35.13% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for XRAY stock in for the last two-week period is set at 60.42, with the RSI for the last a single of trading hit 64.41, and the three-weeks RSI is set at 59.05 for DENTSPLY SIRONA Inc. [XRAY]. The present Moving Average for the last 50 days of trading for this stock 35.08, while it was recorded at 35.46 for the last single week of trading, and 33.90 for the last 200 days.
Insight into DENTSPLY SIRONA Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and DENTSPLY SIRONA Inc. [XRAY] shares currently have an operating margin of +14.91 and a Gross Margin at +55.28. DENTSPLY SIRONA Inc.’s Net Margin is presently recorded at +9.71.
Return on Equity for this stock inclined to 8.25, with Return on Assets sitting at 4.42.
DENTSPLY SIRONA Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.00 and a Current Ratio set at 1.50.
XRAY Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for XRAY. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for DENTSPLY SIRONA Inc. go to 3.90%.
DENTSPLY SIRONA Inc. [XRAY] Insider Position Details
There are presently around $8,477 million, in the hands of institutional investors. The top three institutional holders of XRAY stocks are: VANGUARD GROUP INC with ownership of 25,121,756, which is approximately 1.574% of the company’s market cap and around 0.60% of the total institutional ownership; BLACKROCK INC., holding 16,979,421 shares of the stock with an approximate value of $646.41 million in XRAY stocks shares; and ARTISAN PARTNERS LIMITED PARTNERSHIP, currently with $517.08 million in XRAY stock with ownership of nearly 2.663% of the company’s market capitalization.
Positions in DENTSPLY SIRONA Inc. stocks held by institutional investors increased at the end of Tuesday and at the time of the Tuesday reporting period, where 227 institutional holders increased their position in DENTSPLY SIRONA Inc. [NASDAQ:XRAY] by around 21,703,007 shares. Additionally, 218 investors decreased positions by around 14,166,376 shares, while 69 investors held positions by with 186,795,043 shares. The mentioned changes placed institutional holdings at 222,664,426 shares, according to the latest SEC report filing. XRAY stock had 58 new institutional investments in for a total of 7,676,641 shares, while 69 institutional investors sold positions of 3,606,138 shares during the same period.